Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 29 of 29 publications.

Melen E, Faner R, Allinson JP, Bui D, Bush A, Custovic A, Garcia-Aymerich J, Guerra S, Breyer-Kohansal R, Hallberg J, Lahousse L, Martinez FD, Merid SK, Powell P, Pinnock H, Stanojevic S, Vanfleteren LEGW, Wang G, Dharmage SC, Wedzicha J, Agusti Alvar, Abellan A, CADSET Investigators. Lung-function trajectories: relevance and implementation in clinical practice. Lancet. 2024 Apr 13;403(10435):1494-503. doi: 10.1016/S0140-6736(24)00016-3

Mansfield C, Botha W, Vondeling GT, Klein K, Wang K, Singh J, Hackshaw MD. Patient preferences for features of HER2-targeted treatment of advanced or metastatic breast cancer: a discrete-choice experiment study. Breast Cancer. 2023 Jan;30(1):23-35. doi: 10.1007/s12282-022-01394-6

Reed SD, Zhou X, Ichikawa L, Gatz JL, Peipert JF, Armstrong MA, Raine-Bennett T, Getahun D, Fassett MJ, Postlethwaite DA, Shi JM, Asiimwe A, Pisa F, Schoendorf J, Saltus CW, Anthony MS, APEX-IUD study team. Intrauterine device-related uterine perforation incidence and risk (APEX-IUD): a large multisite cohort study. Lancet. 2022 Jun 4;399(10341):2103-12. doi: 10.1016/S0140-6736(22)00015-0

van der Wall SJ, Lip GYH, Teutsch C, Kalejs O, Lyrer P, Hall C, Dubner SJ, Diener HC, Halperin JL, Ma CS, Rothman KJ, Zint K, Zhai D, Huisman MV, GLORIA-AF Investigators. Low bleeding and thromboembolic risk with continued dabigatran during cardiovascular interventions: the GLORIA-AF study. Eur J Intern Med. 2021 Sep;91:75-80. doi: 10.1016/j.ejim.2021.05.020

Haque R, Shi JM, Telford C, Avila C, Alvarado M, Tiller GE, Dalvi T, Gutierrez L, Tyczynski J, Kaye JA. Survival outcomes in BRCA1 or BRCA2 mutation carriers and the influence of triple-negative breast cancer subtype. Perm J. 2018 Oct 11;22:17-197. doi: 10.7812/TPP/17-197

GBD 2016 Disease and Injury Incidence and Prevalence Collaborators, Gold A. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017 Sep 16;390(10100):P1211-59. doi: 10.1016/S0140-6736(17)32154-2

GBD 2016 Causes of Death Collaborators, Gold A. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017 Sep 16;390(10100):1151-210. doi: 10.1016/S0140-6736(17)32152-9

GBD 2015 Tobacco Collaborators, Gold A. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the global burden of disease study 2015. Lancet. 2017 May 13;389(10082):1885-906. doi: 10.1016/S0140-6736(17)30819-X

Gold R, Esterberg E, Hollombe C, Arkind J, Vakarcs PA, Tran H, Burdick T, Devoe JE, Horberg MA. Low back imaging when not indicated: a descriptive cross-system analysis. Perm J. 2016;20(2):25-33. doi: 10.7812/TPP/15-08

Fine P, Victora CG, Rothman KJ, Moore PS, Chang Y, Curtis V, Heymann DL, Slutkin G, May RM, Patel V, Roberts I, Wortley R, Torgerson C, Deaton A. John Snow's legacy: epidemiology without borders. Lancet. 2013 Apr 1;381(9874):1302-11.

Humphries SE, Hawe E, Dhamrait S, Miller GJ, Talmud PJ. In search of genetic precision. Lancet. 2003;361(9372):1908-1909.

Rothman KJ. Cellular telephones and risk of brain tumours. Lancet. 2001 Mar 24;357(9260):961.

Rothman KJ. Sizing up research. Lancet. 2001 Jan 1;357(9259):890.

Rothman KJ. Cellular telephones and risk of brain tumours - Reply. Lancet. 2001 Jan 1;357(9260):961.

Humphries SE, Talmud PJ, Hawe E, Bolla M, Day IN, Miller GJ. Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study. Lancet. 2001;358(9276):115-9.

Rothman KJ. Epidemiological evidence on health risks of cellular telephones. Lancet. 2000 Nov;356(9244):1837-40.

Kogevinas M, Zock JP, Jarvis D, Kromhout H, Lillienberg L, Plana E. Exposure to substances in the workplace and new-onset asthma: an international prospective population-based study (ECRHS-II). Lancet. 2000 Jul 28;370(9584):336-41.

Rothman KJ, Johnson ES, Sugano DS. Is flutamide effective in patients with bilateral orchiectomy? Lancet. 1999 Apr 3;353(9159):1184. doi: 10.1016/S0140-6736(05)74403-2

Jick H, Garcia Rodriguez LA, Perez-Gutthann S. Principles of epidemiological research on adverse and beneficial drug effects. Lancet. 1998 Nov 28;352(9142):1767-70.

Rothman KJ, Adami HO, Trichopoulos D. Should the mission of epidemiology include the eradication of poverty? Lancet. 1998 Sep 5;352(9130):810-3. doi: 10.1016/S0140-6736(98)01327-0

Rothman KJ. Lessons from John Graunt. Lancet. 1996 Jan 6;347(8993):37-9.

Mines D. Letter to the editor. Of worms and red herrings. Lancet. 1995 Nov 25;346(8987):1438.

Adami HO, Baron J, Rothman KJ. Is a trial of prostate cancer screening ethical? Lancet. 1994 Apr 16;343(8903):958-60. doi: 10.1016/S0140-6736(94)90071-X

Poole C, Rothman KJ, Dreyer NA. Leukemia near Pilgrim nuclear-power plant, Massachusetts. Lancet. 1988 Dec 3;332(8623):1308. doi: 10.1016/S0140-6736(88)92915-7

Townsend TR, Bolyard EA, Yolken RH, Beschorner WE, Bishop (Johannes) CA, Burns WH, Santos GW, Saral R. Outbreak of coxsackie A1 gastroenteritis: a complication of bone-marrow transplantation. Lancet. 1982 Apr 10;1(8276):820-3.

Walker AM, Jick H, Hunter JR, Danford A, Watkins RN, Alhadeff L, Rothman KJ. Vasectomy and non-fatal myocardial infarction. Lancet. 1981 Jan 3;1(8210):13-5.

Rothman KJ, Fyler DC. Seasonal occurrence of complex ventricular septal defect. Lancet. 1974 Jul 27;304(7874):193-7. doi: 10.1016/S0140-6736(74)91486-X

Rothman KJ, Beckman TM. Epidemiological evidence for two types of trigeminal neuralgia. Lancet. 1974 Jan 5;1(7845):7-9. doi: 10.1016/S0140-6736(74)92999-7

MacMahon B, Yen S, Rothman KJ. Potato blight and neural tube defects. Lancet. 1973 Mar 17;301(7803):598-9. doi: 10.1016/S0140-6736(73)90738-1